Exagen Inc
XGN
Company Profile
Business description
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Contact
1261 Liberty Way
VistaCA92081
USAT: +1 760 560-1501
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
179
Stocks News & Analysis
stocks
Ask the analyst: Is the market underestimating Bapcor?
This moated ASX company's shares are in a prolonged slump. I quizzed our analyst Angus Hewitt on its management, the potential impact of EVs, and more.
stocks
Is our ASX best idea still attractive after shares surge?
Shares rose over 21% following the results.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,764.40 | 16.80 | 0.19% |
CAC 40 | 8,006.22 | 33.19 | 0.42% |
DAX 40 | 21,911.74 | 124.74 | 0.57% |
Dow JONES (US) | 44,470.41 | 167.01 | 0.38% |
FTSE 100 | 8,767.80 | 67.27 | 0.77% |
HKSE | 21,492.14 | 29.84 | -0.14% |
NASDAQ | 19,714.27 | 190.87 | 0.98% |
Nikkei 225 | 38,801.17 | 14.15 | 0.04% |
NZX 50 Index | 12,912.25 | 35.90 | 0.28% |
S&P 500 | 6,066.44 | 40.45 | 0.67% |
S&P/ASX 200 | 8,497.20 | 14.40 | 0.17% |
SSE Composite Index | 3,312.47 | 9.70 | -0.29% |